| 2026-04-01 16:01 | CC:PREV | PreveCeutical Medical Inc. | 0.02 | News Release200 | PreveCeutical Adopts Semi-Annual Financial Reporting |
| 2026-03-30 11:36 | CC:PREV | Preveceutical Medical Inc | 0.02 | News Release200 | Preveceutical appoints Pruthi as director |
| 2026-03-12 11:14 | CC:PREV | Preveceutical Medical Inc | 0.02 | News Release200 | Preveceutical investment BioGene names Pruthi director |
| 2026-02-25 11:02 | CC:PREV | Preveceutical Medical Inc | 0.02 | News Release200 | Preveceutical receives Canadian patent allowance |
| 2026-02-09 11:52 | CC:PREV | Preveceutical Medical Inc | 0.025 | News Release200 | Preveceutical files CNS drug delivery patent |
| 2025-12-04 16:41 | CC:PREV | Preveceutical Medical Inc | 0.025 | News Release200 | Preveceutical gets Australian patent for pain therapy |
| 2025-12-01 17:15 | CC:PREV | Preveceutical Medical Inc | 0.025 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2025-12-01 17:15 | CC:PREV | Preveceutical Medical Inc | 0.025 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2025-11-26 16:39 | CC:PREV | Preveceutical Medical Inc | 0.03 | News Release200 | Preveceutical, BioGene complete plan of arrangement |
| 2025-11-24 17:47 | CC:PREV | Preveceutical Medical Inc | 0.03 | Miscellaneous270 | Preveceutical Medical distribution, reclassification |
| 2025-11-24 15:19 | CC:PREV | PreveCeutical Medical Inc. | 0.035 | News Release200 | CSE Bulletin: Notice of Distribution and Reclassification - PreveCeutical Medical Inc. (PREV) |
| 2025-11-20 18:54 | CC:PREV | Preveceutical Medical Inc | 0.04 | News Release200 | Preveceutical clarifies BioGene share issuance |
| 2025-11-20 14:21 | CC:PREV | Preveceutical Medical Inc | 0.025 | News Release200 | Preveceutical to close BioGene deal effective Nov. 24 |
| 2025-10-30 16:17 | CC:PREV | Preveceutical Medical Inc | 0.05 | News Release200 | Preveceutical closes $455k second tranche of placement |
| 2025-10-20 16:57 | CC:PREV | Preveceutical Medical Inc | 0.035 | News Release200 | Preveceutical working to close BioGene arrangement |
| 2025-10-10 17:54 | CC:PREV | Preveceutical Medical Inc | 0.035 | News Release200 | Preveceutical hikes placement, releases AGSM results |
| 2025-09-19 18:08 | CC:PREV | Preveceutical Medical Inc | 0.035 | News Release200 | Preveceutical mails documents for Oct. 10 AGM |
| 2025-09-05 19:06 | CC:PREV | Preveceutical Medical Inc | 0.035 | News Release200 | Preveceutical closes $646,500 tranche one of placement |
| 2025-09-04 16:01 | CC:PREV | PreveCeutical Medical Inc. | 0.035 | News Release200 | PreveCeutical Announces Arrangement Agreement with BioGene Therapeutics |
| 2025-08-29 04:16 | CC:PREV | Preveceutical Medical Inc | 0.04 | News Release200 | Preveceutical reschedules AGM to Oct. 10 |
| 2025-08-20 16:11 | CC:PREV | Preveceutical Medical Inc | 0.035 | News Release200 | Preveceutical's BioGene appoints chief tech officer |
| 2025-08-19 17:07 | CC:PREV | Preveceutical Medical Inc | 0.035 | News Release200 | Preveceutical's BioGene appoints research director |
| 2025-08-05 17:16 | CC:PREV | Preveceutical Medical Inc | 0.03 | News Release200 | Preveceutical further reschedules AGSM to Sept. 29 |
| 2025-07-09 16:16 | CC:PREV | Preveceutical Medical Inc | 0.035 | News Release200 | Preveceutical Medical reschedules AGSM to Sept. 5 |
| 2025-06-30 18:02 | CC:PREV | Preveceutical Medical Inc | 0.03 | News Release200 | Preveceutical appoints Tavares chief technology officer |
| 2025-06-25 16:28 | CC:PREV | Preveceutical Medical Inc | 0.035 | News Release200 | Preveceutical to hold AGM Aug. 15 |
| 2025-06-11 19:01 | CC:PREV | Preveceutical Medical Inc | 0.035 | News Release200 | Preveceutical arranges $750,000 private placement |
| 2025-06-02 16:45 | CC:PREV | Preveceutical Medical Inc | 0.04 | News Release200 | Preveceutical appoints Sampath as corporate adviser |
| 2025-05-30 16:50 | CC:PREV | Preveceutical Medical Inc | 0.045 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2025-05-30 16:50 | CC:PREV | Preveceutical Medical Inc | 0.045 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2025-05-26 15:53 | CC:PREV | Preveceutical Medical Inc | 0.035 | News Release200 | Preveceutical appoints Glover as corporate adviser |
| 2025-05-22 19:35 | CC:PREV | Preveceutical Medical Inc | 0.035 | News Release200 | Preveceutical closes $748,383 private placement |
| 2025-05-14 07:01 | CC:PREV | PreveCeutical Medical Inc. | 0.035 | News Release200 | PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies |
| 2025-04-30 19:12 | CC:PREV | Preveceutical Medical Inc | 0.03 | SEDAR MD & A815 | SEDAR MD & A |
| 2025-04-30 18:59 | CC:PREV | Preveceutical Medical Inc | 0.03 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2025-04-28 20:45 | CC:PREV | Preveceutical Medical Inc | 0.03 | News Release200 | Preveceutical Medical closes first tranche of financing |